Regulation of interactions of endotoxin with host cells

Journal of Endotoxin Research

Volumn 9, Issue 6, 2003, Pages 401-408

  Gioannini, Theresa L ^a,c   Teghanemt, Athmane ^a,c   Zarember, Kol A ^b   Weiss, Jerrold P ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b GENENTECH INC   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BINDING PROTEIN; CARBON 14; CD14 ANTIGEN; CELL RECEPTOR; ENDOTOXIN; LIPOOLIGOSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MEMBRANE PROTEIN; MONOMER; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4;

ARTICLE; BACTERIAL INFECTION; BIOACCUMULATION; BIOASSAY; CELL ACTIVATION; CELL CULTURE; CELL INTERACTION; CELL TRANSPORT; CLEARANCE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HOST CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; ISOTOPE LABELING; MENINGOCOCCOSIS; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PURIFICATION; REGULATORY MECHANISM;

ALBUMINS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; CARBON RADIOISOTOPES; CELL LINE; CHROMATOGRAPHY, GEL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTOXINS; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; NEISSERIA MENINGITIDIS; PROTEIN KINASES; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; UMBILICAL VEINS;

BACTERIA (MICROORGANISMS);

EID: 0346398204     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225002773     Document Type: Article

References (38)

1. Alexander C, Rietschel ETh. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7: 167-202.
2. Heumann D, Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002; 323: 59-72.
3. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11: 19-22.
4. Beutler B. Endotoxin, Toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 2000; 3: 23-28.
5. Nagai Y, Akashi A, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3: 667-672.
6. Bainbridge BW, Darveau RP. Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol Scand 2001; 59: 131-138.
7. Nagai Y, Shimazu R, Ogata H et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 2002; 99: 1699-1705.
8. Perera PY, Mayadas TN, Takeuchi O et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001; 166: 574-581.
9. Tobias PS, Soldau K, Ulevitch RJ. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989; 264: 10867-10876.
10. Hailman E, Lichenstein HS, Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14, J Exp Med 1994; 179: 269-277.
11. Viriyakosol S, Tobias PS, Kitchens RL, Kirkland TN. MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 2001; 276: 38044-38051.
12. Giardina PC, Gioannini T, Buscher B et al. Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions. J Biol Chem 2001; 276: 5883-5891.
13. Weinrauch Y, Foreman A, Shu C et al. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest 1995; 95: 1916-1924.
14. Gioannini TL, Zhang DS, Teghanemt A, Weiss JP. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J Biol Chem 2002; 277: 47818-47825.
15. Munford RS, DeVeaux LC, Cronan Jr JE, Rick PD. Biosynthetic radiolabeling of bacterial lipopolysaccharide to high specific activity. J Immunol Methods 1992; 148: 115-120.
16. De Voe IW, Gilchrist JE. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med 1973; 138: 1156-1167.
17. Eastvold J, Zhang DS, Gioannini TL, Weiss J. Purification and functional characterization of metabolically labeled membrane blebs from an acetate auxotroph of Neisseria meningitidis serogroup B [Abstract]. J Endotoxin Res 2002; 8: 209.
18. Juan TS, Kelley MJ, Johnson DA et al. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J Biol Chem 1995; 270: 1382-1387.
19. Jersmann HP, Hii CS, Hodge GL, Ferrante A. Synthesis and surface expression of CD14 by human endothelial cells. Infect Immun 2001; 69: 479-485.
20. Tobias PS, Soldau K, Iovine NM, Elsbach P, Weiss J. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem 1997; 272: 18682-18685.
21. Iovine N, Eastvold J, Elsbach P, Weiss JP, Gioannini TL. The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes. J Biol Chem 2002; 277: 7970-7978.
22. Thomas CJ, Kapoor M, Sharma S et al. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002; 531: 184-188.
23. Wollenweber HW, Morrison DC. Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative. J Biol Chem 1985; 260: 15068-15074.
24. Dziarski R. Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J Biol Chem 1994; 269: 20431-20436.
25. Elsbach P, Weiss J. Role of the bactericidal/permeability-increasing protein in host defense. Curr Opin Immunol 1998; 10: 45-49.
26. Han J, Mathison JC, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J Biol Chem 1994; 269: 8172-8175.
27. Theofan G, Horwitz AH, Williams RE et al. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J Immunol 1994; 152: 3623-3629.
28. Yu B, Wright SD. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J Biol Chem 1996; 271: 4100-4105.
29. Lamping N, Dettmer R, Schroder NW et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest 1998; 101: 2065-2071.
30. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800-3808.
31. Tobias PS, Tapping RI, Gegner JA. Endotoxin interactions with lipopolysaccharide-responsive cells. Clin Infect Dis 1999; 28: 476-481.
32. Hamann L, Stamme C, Ulmer AJ, Schumann RR. Inhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein. Biochem Biophys Res Commun 2002; 295: 553-560.
33. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320-5325.
34. Tapping RI, Tobias PS. Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem 1997; 272: 23157-23164.
35. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025-1035.
36. Vreugdenhil ACE, Rousseau CH, Hartung T, Greve JWM, van't Veer C, Buurman WA. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003; 170: 1399-1405.
37. Weinrauch Y, Katz SS, Munford RS, Elsbach P, Weiss J. Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect Immun 1999; 67: 3376-3382.
38. Katz SS, Weinrauch Y, Munford RS, Elsbach P, Weiss J. Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate. J Biol Chem 1999; 274: 36579-36584.